✦ LIBER ✦

Interlaboratory variability in assessment of the model of end-stage liver disease score

✍ Scribed by Ton Lisman; Yvonne Van Leeuwen; Jelle Adelmeijer; Ilona T. A. Pereboom; Elizabeth B. Haagsma; Arie P. Van Den Berg; Robert J. Porte

Book ID: 111237927
Publisher: John Wiley and Sons
Year: 2008
Tongue: English
Weight: 88 KB
Volume: 28
Category: Article
ISSN: 0106-9543
DOI: 10.1111/j.1478-3231.2008.01783.x

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Model for end-stage liver disease except

Model for end-stage liver disease exceptions in the context of the french model for end-stage liver disease score–based liver allocation system

✍ Claire Francoz; Jacques Belghiti; Denis Castaing; Olivier Chazouillères; Jean-Ch 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 437 KB 👁 1 views

Model for End-Stage Liver Disease (MELD) score-based allocation systems have been adopted by most countries in Europe and North America. Indeed, the MELD score is a robust marker of early mortality for patients with cirrhosis. Except for extreme values, high pretransplant MELD scores do not signific

Clinically relevant differences in the M

Clinically relevant differences in the Model for End-Stage Liver Disease and Model for End-Stage Liver Disease–sodium scores

✍ Rhiana Garritsen; Andrei Tintu; Herold Metselaar; Geert Kazemier 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 38 KB 👁 1 views

With interest, we read the article by Xiol et al. 1 regarding differences in serum measurements between different laboratories and their influence on the Model for End-Stage Liver Disease (MELD) and the Model for End-Stage Liver Disease incorporating serum sodium (MELD-Na). They reported significant

Reply: Clinically relevant differences i

Reply: Clinically relevant differences in the model for end-stage liver disease and model for end-stage liver disease–sodium scores

✍ Xavier Xiol; Jose Castellote; Xavier Fuentes-Arderiu 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 37 KB 👁 1 views

We thank Garritsen et al. 1 for their interest in our article about differences in Model for End-Stage Liver Disease (MELD) and Model for End-Stage Liver Disease-Sodium (MELD-Na) scores determined at 3 different laboratories. 2 We agree that one of the important messages of our article is the import

The model for end-stage liver disease sc

The model for end-stage liver disease score and posttransplant biliary complications

✍ Domingo Balderramo; Andres Cardenas 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 40 KB 👁 1 views

The extent of hepatectomy depends on the

The extent of hepatectomy depends on the preoperative model for end-stage liver disease score

✍ James D. Perkins 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 81 KB 👁 1 views

Objective: To produce a model indicating the extent of hepatectomy for hepatocellular carcinoma on cirrhosis based on easily available preoperative data. Design: Retrospective study based on multicenter prospectively updated databases. Setting: Two tertiary referral centers specializing in hepatobil

Model for end-stage liver disease, model

Model for end-stage liver disease, model for end-stage liver disease-sodium and Child–Turcotte–Pugh scores over time for the prediction of complications of liver cirrhosis

✍ Pil Cho Choi; Hong Joo Kim; Woo Hyuk Choi; Dong Il Park; Jung Ho Park; Yong Kyun 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 148 KB